ClinicalTrials.gov
public full text
Public Domain
JY028 Single Vitreous Injection in a Phase 1 Clinical Trial in nAMD Patients
Phase I clinical trial on safety, tolerance, pharmacokinetics (PK) and pharmacodynamics of recombinant human anti-VEGF monoclonal antibody injection in patients with neovascular (wet) age-related macular degeneration
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD)#1139709
- Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration#910203
- A Dose Escalation Study of IBI333 in Subjects With Neovascular Age-related Macular Degeneration#1152517
- Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD#913086
- Ranibizumab Plus Indomethacin#1164498
Record · ID 1094977
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive